Unichem Laboratories Limited Partially Wins GST Appeal, Demand Reduced to ₹10.59 Lakhs
Unichem Laboratories Limited's appeal for GSTR TRAN 1 credit has been partially allowed by the Additional Commissioner, CGST (Appeals), Dehradun. The demand has been reduced to ₹10,59,354/- plus interest. The company does not anticipate a material financial or operational impact and plans to file a further appeal.
The company explicitly stated that there will be no material impact on its financial, operational, or other activities, despite the demand raised.
While the company partially won its appeal, a demand of over ₹10.59 lakhs plus interest has been raised. The company plans to appeal further, indicating an ongoing legal process with an uncertain outcome.
Unichem Laboratories Limited has received a communication regarding an order passed by the Additional Commissioner, Central Goods & Services Tax, (Appeals), Dehradun. This order partially allows the company's appeal concerning GSTR TRAN 1 credit.
Previously, an appeal was filed against an order by the Asst. Commissioner, Central Goods and Service Tax, Dehradun, for the disallowance of TRAN 1 credit amounting to ₹73,02,757/- under Section 140(3) of the CGST Act, 2017, and also for ₹73,02,757/- under Sections 74 & 122 of the CGST Act.
The Additional Commissioner, CGST (Appeals), Dehradun, has now partially allowed the GSTR TRAN 1 credit, resulting in a revised demand of ₹10,59,354/- plus applicable interest under Section 50. The company received this order on 28th July 2026, after 3:00 p.m. The original violation alleged was the partial disallowance of GSTR TRAN 1 credit.
Unichem Laboratories stated that there will be no material impact on its financial, operational, or other activities. The company, based on legal advice, intends to take appropriate steps, including filing a further appeal against this order within the prescribed timelines.
What to do with a filing like this
Unichem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under regulatory impact. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Unichem Laboratories Limited. Read the original for the full detail.